Zogenix Inc - Company Profile

Powered by

All the data and insights you need on Zogenix Inc in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Zogenix Inc Strategy Report

  • Understand Zogenix Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Zogenix Inc: Overview

Select Item

Zogenix Inc, a subsidiary of UCB SA, is a biopharmaceutical company engaged in research and development of novel therapies for the treatment of rare diseases. The company is headquartered in Emeryville, California, the US.

 Gain a 360-degree view of Zogenix Inc and make more informed decisions for your business Gain a 360-degree view of Zogenix Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address Suite 500, 5959 Horton Street, Emeryville, California, 94608
Industry Pharmaceuticals and Healthcare
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Zogenix Inc premium industry data and analytics

50+

Clinical Trials

Determine Zogenix Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Zogenix Inc’s relevant decision makers and contact details.

30+

Catalyst Calendar

Proactively evaluate Zogenix Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

6

Pipeline Drugs

Identify which of Zogenix Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand Zogenix Inc’s commercialized product portfolio to stay one step ahead of the market.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Zogenix Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Zogenix Inc key executives to enhance your sales strategy Gain insight into Zogenix Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward